Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000240347) titled 'Q-Inform: A randomised control trial of risk stratified screening advice for melanoma' on Feb. 25.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: QIMR Berghofer
Condition:
Melanoma
Melanoma
Public Health - Epidemiology
Cancer - Malignant melanoma
Skin - Dermatological conditions
Intervention:
We plan a 3-arm blinded RCT to assess the effect of personalised genetic or clinical risk for skin cancer on skin screening behaviour. Participants currently partic...